Adverum Biotechnologies Inc (ADVM)
7.67
+0.26
(+3.51%)
USD |
NASDAQ |
Nov 04, 13:15
Adverum Biotechnologies Price to Book Value: 0.9495 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 0.9173 |
| October 31, 2024 | 0.9031 |
| October 30, 2024 | 0.9755 |
| October 29, 2024 | 0.9606 |
| October 28, 2024 | 0.9804 |
| October 25, 2024 | 0.9879 |
| October 24, 2024 | 1.000 |
| October 23, 2024 | 1.005 |
| October 22, 2024 | 1.008 |
| October 21, 2024 | 1.022 |
| October 18, 2024 | 1.050 |
| October 17, 2024 | 1.000 |
| October 16, 2024 | 1.016 |
| October 15, 2024 | 0.952 |
| October 14, 2024 | 0.9569 |
| October 11, 2024 | 0.947 |
| October 10, 2024 | 0.921 |
| October 09, 2024 | 0.9309 |
| October 08, 2024 | 0.9421 |
| October 07, 2024 | 0.921 |
| October 04, 2024 | 0.9322 |
| October 03, 2024 | 0.9012 |
| October 02, 2024 | 0.8443 |
| October 01, 2024 | 0.8158 |
| September 30, 2024 | 0.869 |
| Date | Value |
|---|---|
| September 27, 2024 | 0.8591 |
| September 26, 2024 | 0.8183 |
| September 25, 2024 | 0.8158 |
| September 24, 2024 | 0.8591 |
| September 23, 2024 | 0.8517 |
| September 20, 2024 | 0.9272 |
| September 19, 2024 | 0.9285 |
| September 18, 2024 | 0.8653 |
| September 17, 2024 | 0.9037 |
| September 16, 2024 | 0.8926 |
| September 13, 2024 | 0.895 |
| September 12, 2024 | 0.8727 |
| September 11, 2024 | 0.8703 |
| September 10, 2024 | 0.8888 |
| September 09, 2024 | 0.8616 |
| September 06, 2024 | 0.8368 |
| September 05, 2024 | 0.8443 |
| September 04, 2024 | 0.8381 |
| September 03, 2024 | 0.8368 |
| August 30, 2024 | 0.8591 |
| August 29, 2024 | 0.8517 |
| August 28, 2024 | 0.8567 |
| August 27, 2024 | 0.8963 |
| August 26, 2024 | 0.9247 |
| August 23, 2024 | 0.9062 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2585
Minimum
Dec 27 2022
7.297
Maximum
Feb 18 2020
1.752
Average
0.8996
Median
May 22 2024
Price to Book Value Benchmarks
| EyePoint Pharmaceuticals Inc | 2.785 |
| Cassava Sciences Inc | 6.588 |
| Regenxbio Inc | 1.245 |
| Editas Medicine Inc | 1.049 |
| Apellis Pharmaceuticals Inc | 13.52 |
Price to Book Value Related Metrics
| Price | 7.67 |
| Earnings Yield | -104.2% |
| Market Cap | 159.54M |